Women produce physiological data that is just as predictable as men, at least when it comes to skin temperature. This might seem like common sense, but...
WEST LAFAYETTE, Ind. – A Purdue researcher is taking a giant leap forward in the fight against drug-resistant strains of malaria in developing countries....
Private equity company Permira has acquired publicly-listed pharma service provider Ergomed in a cash agreement worth £703.1 million ($883 million), with...
Fauci Defended NIH Culture Of Secrecy: The $325M Third-Party Royalty Complex... Now We Know The Details By Adam Andrzejewski, author of OpenTheBooks...
Lack of access, strict regulations, and demanding schedules have made it extremely difficult for patients to participate in The post Steps to building...
Anthony Fauci: From AIDS To COVID-19, A Pharma Love Story Opinion authored by Lorenzo Puertas via The Epoch Times (emphasis ours), After...
For most of my adult life, I had been the typical American fat guy, gaining a pound or The post Fatty liver disease: With little early...
Cholesterol tends to get a bad rap through its association with cardiovascular disease. But its role in the body is much more nuanced. Credit: (Jason Sheldon/UConn...
California Poised To Adopt 'Medical Misinformation Bill' Targeting Alternative COVID-19 Protocols Authored by Patricia Tolson via The Epoch...
The U.S. Food and Drug Administration decided not to authorize the antidepressant fluvoxamine to treat COVID-19, saying the data has not shown the drug...
The Anatomy Of Big Pharma's Political Reach Authored by Rebecca Strong via Medium.com, They keep telling us to “trust the science.” But...
Markets open higher today after jobs report release. The post Stock Market Today: Dow Jones, S&P 500 Rebounds; GameStop (GME) Seeks Stock Split Amid...
Those who are allergic to peanut butter: rejoice. Allergy Therapeutics’ virus-like particle peanuts allergy candidate is about to enter Phase I trials,...
Sunday Collum: 2021 Year In Review, Part 2 - Heart Of Darkness & The Rise Of Centralized Healthcare Authored by David B. Collum, Betty R. Miller...
Insights editors choose their top long reads of the year.
Bloomberg reports this week that the VIX (the CBOE Volatility Index) is rallying with the S&P 500 in a rare way over the past few weeks....
As people have become more conscious and vocal about diversity and inclusion, Page & Page’s Lisa Lishman says The post Treatment for all: the key steps...
Psychedelics industry executives share their perspectives on hitting the public market as interest in the space continues to grow. The post Going Public: Psychedelics Execs Talk...
Investors in a biotech startup developing a COVID-19 treatment claim the firm’s leaders cashed out as stock prices surged during a publicity blitz for a drug...
The media reporting on Indigenous vaccine hesitancy is as sensational as it is incorrect. Indigenous people, for the most part, are not more vaccine hesitant than...
There is still no cure for COVID-19, but doctors have several innovative treatments. Some are keeping patients out of the hospital entirely.
A survey by rare disease patient network Raremark found that 86% of the community members asked were interested The post Unlocking the potential in rare disease...
Credit: Daniel Fletcher and Melanie Ott Researchers have developed an assay that can detect the presence of SARS-CoV-2 in a nasal swab using a device attached...
Market Breaks Out On Vaccine Hopes As Cases Surge
Market Breaks Out On Vaccine Hopes As Cases Surge 11-13-20
Deutsche Bank Returns With Updated Primer On Global Race For COVID-19 Vaccine
China COVID-19 Vaccine Trial Halted In Brazil After Reports Of Patient's Death
Eli Lilly to continue other Covid-19 antibody drug trials after pausing one on safety concerns
S&P Futures Inexplicably Dip As "Magical, Non-Stop Rally" Reverses
UPDATED: The leaders in the race to develop a Covid-19 vaccine say they could have pivotal data in October — but Trump claims FDA is slowing...